T3 Companies, LLC

Position in LQDA — Liquidia Corp

CIK 2052441 NEW YORK, NY

Position in LQDA

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$7,000,294

-$764,711 QoQ

Shares Held

87,800

-57.3% QoQ

Ownership

0.098%

of shares outstanding

% of Portfolio

8.91%

of 13F equity value

Holder Rank

#72

of 333 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

T3 Companies, LLC holds $7,960,424 across 5 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (87.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp This page	87,800	$7,000,294
2	NBIX	Neurocrine Biosciences Inc	2,000	$337,080
3			82,500	$260,700
4	HROW	Harrow, Inc.	5,000	$212,350
5	BCRX	Biocryst Pharmaceuticals Inc	15,000	$150,000

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,000,294	87,800	-57.3%	Shares	Sole	2026-07-27
2026-03-31	$7,765,005	205,750	+16.6%	Shares	Sole	2026-05-07
2025-12-31	$6,084,070	176,401	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.